Abbott Laboratories
ABT
46 Followers
22 January
Upcoming Earnings
Market Cap.
P/E
ABT Fair Price
$935.20
Overvalued by 32.4%
To display the fair price of a share, you need to be a member of Bulios Black.
My Notes
Začít psátFeed
Read More
Abbott Laboratories beat expectations with a quarterly profit thanks to strong medical device sales.
Sales of glucose monitoring products were particularly strong.
An increase in demand for medical interventions supported overall growth.
Annual earnings of 98 cents per share beat analysts' estimates by 3 cents.
Abbott Laboratories $ABT raised its full-year forecast to $4.55 to $4...
Read more
Read More
📈 Investment Jewels in Healthcare 📈
Hello BuliosiansI have three kings of the healthcare industry here today! 💰
Johnson & Johnson $JNJ
Withover 62 years of consistent dividends and a AAA credit rating, JNJ isan interesting choice. The company is focused on pharmaceuticals, medical devices and technology, emphasizing consistency and durability. With a historically low forward P...
Read more
Zobrazit další komentáře
I'm not familiar with this company, but it looks interesting.
Thanks for the tip.
JNJ doesn't really appeal to me, but I'm not familiar with the other two and I'm intrigued, so thanks for the tip. Otherwise, from the health care industry even though it's also a bit of a REIT I liked $CVS.